Anthony Battram

Grupo de investigación

Trasplante de progenitores hemopoyéticos Post-doctoral researcher (R2A)

battram@recerca.clinic.cat 0000-0002-9179-0639

Síguelo/a en:

Publicaciones destacadas

Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia

Autores:
Moreno DF; López-Guerra M; Paz S; Oliver-Caldés A; Mena MP;

(...)

Jiménez-Segura R; Bladé J; Rosiñol L; Colomer D; Fernández de Larrea C .

Referencia: British Journal Of Haematology 2023.
T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells

Autores:
Battram, Anthony M; Oliver-Caldes, Aina; Suarez-Lledo, Maria; Lozano, Miquel; Crespo, Miquel Bosch i;

(...)

Cid, Joan; Moreno, David F; Rodriguez-Lobato, Luis Gerardo; Urbano-Ispizua, Alvaro; de Larrea, Carlos Fernandez.

Referencia: Molecular Therapy-Methods & Clinical Development 2022.
IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation

Autores:
Battram, AM; Bachiller, M; Lopez, V; de Larrea, CF; Urbano-Ispizua, A;

Martín-Antonio, B.

Referencia: Cancers 2021.
NK cells enhance CAR-T cell antitumor efficacy by enhancing immune/tumor cells cluster formation and improving CAR-T cell fitness

Autores:
Bachiller, Mireia; Perez-Amill, Lorena; Battram, Anthony Matthew; Carne, Sebastian Ciro; Najjar, Amer;

Verhoeyen, Els; Juan, Manel; Urbano-Ispizua, Alvaro; Martin-Antonio, Beatriz.

Referencia: Journal For Immunotherapy Of Cancer 2021.
Natural killer cells in immunotherapy: Are we nearly there?

Autores:
Bachiller M; Battram AM; Perez-Amill L; Martín-Antonio B;

Referencia: Cancers 2020.
BCMA-TARGETING CAR-T CELLS EXPANDED IN IL-15 HAVE AN IMPROVED PHENOTYPE FOR THERAPEUTIC USE COMPARED TO THOSE GROWN IN IL-2 OR IL-15/IL-7

Autores:
Battram, Anthony; Bachiller, Mireia; Urbano-Ispizua, Alvaro; Martin-Antonio, Beatriz;;

Referencia: Journal For Immunotherapy Of Cancer 2020.
CORD-BLOOD DERIVED NK CELLS, AND CAR-T CELLS, AN ATTRACTIVE IMPROVED IMMUNOTHERAPY TREATMENT TO BE CONSIDERED FOR HEMATOLOGICAL MALIGNANCIES

Autores:
Garcia, Mireia Bachiller; Perez-Amill, Lorena; Battram, Anthony; Urbano-Ispizua, Alvaro; Martin-Antonio, Beatriz;;

Referencia: Journal For Immunotherapy Of Cancer 2020.
Senescence in the development and response to cancer with immunotherapy: A double-edged sword

Autores:
Battram AM; Bachiller M; Martín-Antonio B;

Referencia: International Journal Of Molecular Sciences 2020.
The Phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) Binder Rasa3 Regulates Phosphoinositide 3-kinase (PI3K)-dependent Integrin αIIbβ3 Outside-in Signaling

Autores:
Battram AM; Durrant TN; Agbani EO; Heesom KJ; Paul DS;

(...)

Poole AW; Cullen PJ; Bergmeier W; Moore SF; Hers I .

Referencia: Journal Of Biological Chemistry 2017.

Proyectos destacados

Estrategias para superar las recaídas por escape antigénica y mejorar la persistencia de las células CART en el mieloma múltiple

Investigador/a principal: Carlos Fernández de Larrea Rodríguez

Financiador: Asociación Española Contra el Cáncer (AECC)

Código: LABAE21971FERN

Duración: 01/11/2021 - 31/10/2024

Anthony Battram

Grupo de investigación

Publicaciones destacadas

Proyectos destacados

Estrategias para superar las recaídas por escape antigénica y mejorar la persistencia de las células CART en el mieloma múltiple

Suscríbete a la Newsletter del Clínic